We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AURA icon
6026
Aura Biosciences
AURA
$819M
-31,281
Closed -$290K
AUTL
6027
Autolus Therapeutics
AUTL
$623M
-360,145
Closed -$663K
AVB
6028
DELISTED
AvalonBay Communities
AVB
-136,253
Closed -$24.3M
AVDL
6029
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
-250,000
Closed -$2.29M
AVDL
6030
DELISTED
Avadel Pharmaceuticals
AVDL
-288,910
Closed -$2.65M
AVO icon
6031
Mission Produce
AVO
$1.16B
-29,502
Closed -$328K
AVTR icon
6032
CALL
Avantor
AVTR
$9.64B
-40,000
Closed -$846K
AVY icon
6033
Avery Dennison
AVY
$13.9B
-352,467
Closed -$63.1M
AWF
6034
AllianceBernstein Global High Income Fund
AWF
$872M
-11,553
Closed -$112K
BAM icon
6035
Brookfield Asset Management
BAM
$83.6B
-172,756
Closed -$5.65M
BAND
6036
Bandwidth Inc
BAND
$1.49B
-121,171
Closed -$1.84M
BANF icon
6037
BancFirst
BANF
$3.78B
-27,778
Closed -$2.31M
BANL icon
6038
CBL International Ltd
BANL
$28.9M
-1,147
Closed -$142K
BARK icon
6039
BARK
BARK
$92.1M
-4,115
Closed -$119K
BBEU icon
6040
JPMorgan BetaBuilders Europe ETF
BBEU
$9.55B
-21,104
Closed -$1.13M
BBIO icon
6041
BridgeBio Pharma
BBIO
$15.8B
-310,569
Closed -$4.67M
BBLG
6042
Bone Biologics
BBLG
$1.67M
-12
Closed -$5K
BBN icon
6043
BlackRock Taxable Municipal Bond Trust
BBN
$973M
-14,244
Closed -$255K
BBSI icon
6044
Barrett Business Services
BBSI
$810M
-42,140
Closed -$934K
BBUC
6045
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.8B
-55,033
Closed -$1.09M
BCRX icon
6046
PUT
BioCryst Pharmaceuticals
BCRX
$2.47B
-56,800
Closed -$474K
BCS icon
6047
PUT
Barclays
BCS
$90.7B
-300,000
Closed -$2.16M
BDN
6048
Brandywine Realty Trust
BDN
$548M
-1,706,657
Closed -$8.07M
BEN icon
6049
Franklin Templeton
BEN
$17.6B
-677,355
Closed -$17.5M
BEPC icon
6050
Brookfield Renewable
BEPC
$6.1B
-17,066
Closed -$596K

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.